Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

EpCAM Recombinant monoclonal antibody (EGP40/1556R)

 
ENZ-ABS365-0100 100 µg 440.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:Epithelial cell adhesion molecule, Epithelial specific antigen, ESA, CD326
 
Clone:EGP40/1556R
 
Host:Rabbit
 
Isotype:IgGκ
 
Immunogen:Recombinant human EpCAM.
 
UniProt ID:P16422
 
Species reactivity:Human
 
Applications:Flow Cytometry, IF, IHC (PS), WB
 
Recommended Dilutions/Conditions:Flow Cytometry (0.5-1 µg/106 cells in 0.1 mL)
Immunofluorescence (1-2 µg/mL)
Immunohistochemistry (formalin-fixed paraffin sections) (0.5-1 µg/mL for 30 min at RT)
Western blot (0.5-1 µg/mL)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Purity Detail:Protein A affinity purified.
 
Formulation:Liquid. In 1X PBS containing 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:+4°C
 
Scientific Background:Epithelial cellular adhesion molecule (EpCAM), is also identified as epithelial specific antigen (ESA) and the 40kDa transmembrane epithelial glycoprotein EGP40. EpCAM is expressed on the baso-lateral cell surface in most simple epithelia and a vast majority of carcinomas. EpCAM antibody is also useful in distinguishing serous carcinomas of the ovary from mesothelioma.
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
EpCam
By biological activity:
EpCam Recombinant antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

Product Flyers
Recombinant Antibodies (rAb)
Recombinant Antibodies (rAb)
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,